Trials / Completed
CompletedNCT04949230
A Retrospective Study of COVID-19 Treatments
A Retrospective Study to Analyze Efficacy of COVID-19 Treatments
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 300 (actual)
- Sponsor
- ProgenaBiome · Academic / Other
- Sex
- All
- Age
- 18 Months
- Healthy volunteers
- Not accepted
Summary
Surveys administered to subjects who have recovered from COVID-19 to assess how effective their treatment was.
Detailed description
Subjects who have recovered from COVID-19 will answer questions regarding the severity of their illness, symptoms experienced, what treatment they received, and how long they were ill.
Conditions
- Covid19
- COVID-19 Pneumonia
- COVID-19 Respiratory Infection
- COVID-19 Acute Bronchitis
- COVID-19 Acute Respiratory Distress Syndrome
- COVID-19 Lower Respiratory Infection
- SARS-CoV2 Infection
- SARS-CoV-2 Acute Respiratory Disease
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No Intervention Used | There is no intervention in this study |
Timeline
- Start date
- 2021-02-19
- Primary completion
- 2024-02-15
- Completion
- 2024-02-15
- First posted
- 2021-07-02
- Last updated
- 2024-02-29
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT04949230. Inclusion in this directory is not an endorsement.